EID Parry Q2 Results: Revenue Growth, Profitability Declines
EID Parry India Limited (EID Parry) has announced its financial results for the second quarter of the fiscal year 2024 (Q2 FY24), ending September 30, 2024. The company reported mixed …
HAL Q2 2024 Financial Results: Impressive Growth in Sales and Profits
Hindustan Aeronautics Limited (HAL) has reported strong financial results for the second quarter of fiscal year 2024. The company achieved impressive revenue and profit growth compared to both the previous …
IPCALAB Reports Robust Q2 2024 Results with Strong Sales Growth and Stable Profit Margins
IPCALAB, a major Indian pharmaceutical company, has announced its financial results for the second quarter of the 2024 fiscal year, ending September 2024. The results reveal substantial year-over-year growth in …
TECHNOE Q2 2024 Results: 18% QoQ Sales Growth with Improved Margins and Strong Operating Profit
TECHNOE, a prominent Indian company, has released its financial results for the quarter ending September 2024 (Q2 FY2024). The company recorded impressive growth in sales and operating profit margins, reinforcing …
SUN TV Q2 2024 Results Showcase Profitability and Performance Amid Year-over-Year Comparisons.
SUN TV Network Limited has announced its Q2 results for the period ending in September 2024. The financial figures show a robust operational structure, with slight variances in comparison to …
Eicher Motors Q2 FY 2025 Results: Analysis and Comparison with Q1 FY 2025 and Q2 FY 2024 Performance
Eicher Motors Limited (EICHERMOT) recently announced its financial results for the quarter ending September 2024 (Q2 2024). This report examines the company’s Q2 2024 performance, providing a comparative view with …
SOLARINDS Q2 2024 Results: Strong Revenue Growth and Increased Net Profit
SOLARINDS Q2 Financial Results SOLARINDS Q2 Financial Results Metric Sep 2024 Jun 2024 Sep 2023 Sales (Rs. Crore) 1716.00 1685.00 1347.00 Net Profit (Rs. Crore) 304.00 301.00 209.00 Operating Profit …
WOCKPHARMA Q2 2024 Results: Revenue Up to Rs. 809 Crore, Net Loss Narrows to Rs. 16 Crore from Rs. 73 Crore YoY
NSE:WOCKPHARMA:Rs.1,203.00 (+1.88%) Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments). Revenue Revenue for the current quarter …
ALKEM Q2 Results: Revenue declined by 0.73% year-over-year (YoY) to Rs. 3415 crore, while net profit rose by 14.15% YoY to Rs. 702 crore.
NSE: ALKEM: Rs.5,565.15 (+1.12%) Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. Revenue …